Tocilizumab drug may help fight severe coronavirus cases, study finds

Updated:5 years, 6 months ago

New Delhi, May 01 (ANI): An antibody treatment, using the drug tocilizumab, may be represented as an effective option in severe coronavirus cases, according to a preliminary report by Xiaoling Xu et al, published in PNAS. Tocilizumab-- as a recombinant humanized anti-human IL-6 receptor monoclonal antibody, has shown benefits 'clinically' in patients who had contracted the coronavirus disease. Severe COVID-19 cases are associated with activation of large numbers of T lymphocytes and inflammatory monocytes and elevated levels of cytokines, particularly interleukin-6 (IL-6). In this study, researchers Haiming Wei, Xiaoling Xu, and colleagues examined the effects of treating 21 severe or critical COVID-19 patients, aged between 25-88 years, in Anhui Province, China. The team observed tocilizumab in the treatment of 21 patients with COVID-19, who prior to the treatment were presented with fever and lung lesions. 17 patients had abnormally low lymphocyte percentages and 20 patients had elevated levels of C-reactive protein (CRP), a marker of inflammation. All but one patient received oxygen therapy prior to treatment. All patients' body temperatures returned to normal on the first day after receiving tocilizumab and remained stable thereafter. Within five days of treatment, 15 patients were able to reduce their oxygen intake, and lymphocyte percentages and CRP had returned to normal in 10 and 16 patients, respectively. Lung lesions were absorbed in 19 patients after treatment. All patients were discharged between 10 and 31 days after treatment, and no adverse reactions to treatment were reported. Although the results are preliminary, clinical data showed that the symptoms, hypoxygenmia, and CT opacity changes were improved immediately after the treatment with tocilizumab in most of the patients, suggesting that tocilizumab could be an efficient therapy for the treatment of COVID-19.

Top Videos

Updated:4 years, 9 months ago

Pan-India dry run for COVID vaccine tomorrow: Harsh Vardhan

Updated:4 years, 9 months ago

PM Modi joins world leaders in condemning US Capitol siege

Updated:4 years, 10 months ago

Indo-Japan Samvad: Buddha’s message spread out from India to world, says PM Modi

Updated:4 years, 10 months ago

Centre preparing with states for past 4 months for COVID-19 vaccination: Harsh Vardhan

Updated:4 years, 10 months ago

In Jan, India may be in position to give 1st COVID vaccine shot: Harsh Vardhan

Updated:4 years, 10 months ago

Worst is over but still need to be cautious: Health Minister on COVID-19 cases in India

Tocilizumab drug may help fight severe coronavirus cases, study finds

Top Videos

Related Video

Aggressive intervention recommended to prevent pediatric diabetes, finds study

Study reveals high fat diets may over-activate destructive heart disease protein

Consuming diet high in poor quality carbohydrates linked to heart attacks, death risk

Researchers find light activities may help women's mobility during ageing

COVID antibodies are transferred from pregnant women to their babies

Overweight, diabetic people at risk of developing nonalcoholic fatty liver disease

Study reveals factors linked with elevated risk of bone fracture

Damage to heart found in more than half of COVID-19 patients discharged from hospital

LGB people more prone to mental health disorders, alcohol misuse

Unacceptably high levels of carcinogens inhaled by commuters

Post-surgery in kids, aspirin preferred to prevent blood clots

Coffee consumption related with decreased heart failure risk

Study reveals high blood pressure causes atrial fibrillation

Greater retail availability of marijuana, alcohol linked with co-use among teens

COVID-19 patients have higher risk of dying after cardiac arrest

World Cancer Day: Understanding role of nutrition, lifestyle changes to control cancer

Pregnancy complications increase risk of heart disease in women

Antibiotic may improve depressive symptoms in people with low-level inflammation: Study

Serious complications during pregnancy linked to higher risk of death: Study

Study reveals what causes irritable bowel syndrome